Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamphenicol glycinate acetylcysteinate sequential systemic plus aerosol vs aerosol-only vs standard therapy for upper respiratory tract infections
2004-001901-81Phase 3Terminated
- Sponsor
- AISAR
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of thiamphenicol glycinate acetylcysteinate in upper respiratory infection (URI) (3 arms), sponsored by AISAR. Started Mar 2007; status: terminated.
02
Drugs
thiamphenicol glycinate acetylcysteinate
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on 2004-001901-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001901-81.